Interleukin-6 and insulin sensitivity: friend or foe? (Q35829806)

10 August 2017

1 reference

title

Interleukin-6 and insulin sensitivity: friend or foe? (English)

1 reference

10 August 2017

A L Carey

1

1 reference

PubMed ID

15241593

10 August 2017

M A Febbraio

series ordinal

2

1 reference

10 August 2017

7 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

47

1 reference

10 August 2017

1135-1142

1 reference

10 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-004-1447-y

10 August 2017

0 references

cites work

Role of cytokines in inducing hyperlipidemia

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Mechanisms of TNF-alpha-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Muscle-derived interleukin-6: mechanisms for activation and possible biological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Biological and clinical aspects of interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

The soluble interleukin-6 receptor is generated by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Molecular basis of the cell specificity of cytokine action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

A family of cytokine-inducible inhibitors of signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Hepatosplanchnic clearance of interleukin-6 in humans during exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin (IL)-6 mRNA Expression is Stimulated by Insulin, Isoproterenol, Tumour Necrosis Factor Alpha, Growth Hormone, and IL-6 in 3T3-L1 Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 gene expression is increased in insulin-resistant rat skeletal muscle following insulin stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Effect of proinflammatory interleukins on jejunal nutrient transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Cytokine regulation of facilitated glucose transport in human articular chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Comparison of the effects of insulin, PDGF, interleukin-6, and interferon-gamma on glucose transport in 3T3-L1 cells: lack of cross-talk between tyrosine kinase receptors and JAK/STAT pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 gene polymorphism and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Dose-dependent effects of recombinant human interleukin-6 on glucose regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Metabolic effects of interleukin-6 in human splanchnic and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6-deficient mice develop mature-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1447-Y

Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes

21 January 2018

1 reference

12 December 2020

The effects of infection of thermal injury by Pseudomonas aeruginosa PAO1 on the murine cytokine response

1 reference

12 December 2020

Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3.

1 reference

12 December 2020

Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells

1 reference

12 December 2020

Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

1 reference

12 December 2020

Effect of prolonged, submaximal exercise and carbohydrate ingestion on monocyte intracellular cytokine production in humans

1 reference

12 December 2020

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

12 December 2020

Inhibition by recombinant human interleukin-6 of the glucagon-dependent induction of phosphoenolpyruvate carboxykinase and of the insulin-dependent induction of glucokinase gene expression in cultured rat hepatocytes: regulation of gene transcriptio

1 reference

12 December 2020

Endocrine and carbohydrate responses to interleukin-6 in vivo

1 reference

12 December 2020

Interleukin-6 stimulates hepatic triglyceride secretion in rats

1 reference

12 December 2020

Increased secretion of tumour necrosis factor and interleukin 6 from isolated, perfused liver of rats after partial hepatectomy

1 reference

12 December 2020

Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans.

1 reference

12 December 2020

Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.

1 reference

12 December 2020

Relationship of TNF to interleukins

1 reference

12 December 2020

RETRACTED: Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise

1 reference

12 December 2020

Cytokines and type 2 diabetes mellitus

1 reference

12 December 2020

The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.

1 reference

12 December 2020

Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running.

1 reference

12 December 2020

Gene expression of receptors for IL-6, LIF, and CNTF in regenerating skeletal muscles

1 reference

12 December 2020

The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site

1 reference

12 December 2020

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

1 reference

12 December 2020

Intracerebroventricular interleukin-6 treatment decreases body fat in rats

1 reference

12 December 2020

High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production

1 reference

12 December 2020

Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge

1 reference

12 December 2020

Evidence for IL-6 production by and effects on the pancreatic beta-cell

1 reference

12 December 2020

Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro

1 reference

12 December 2020

Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus

1 reference

12 December 2020

1 reference

12 December 2020

Endocrinologic and metabolic effects of interleukin-6 in humans

1 reference

12 December 2020

Circulating interleukin 6 concentrations and insulin resistance in patients with cancer

1 reference

12 December 2020

Cytokines and endotoxin induce cytokine receptors in skeletal muscle

1 reference

12 December 2020

Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity.

1 reference

12 December 2020

Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells

1 reference

12 December 2020

Effects of cytokines on the liver

1 reference

12 December 2020

Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways

1 reference

12 December 2020

Autocrine up-regulation of glucocorticoid receptors by interleukin-6 in human osteoblast-like cells

1 reference

12 December 2020

Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle

1 reference

12 December 2020

Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene

1 reference

12 December 2020

10.1007/S00125-004-1447-Y

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15241593